NO152651C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol

Info

Publication number
NO152651C
NO152651C NO783968A NO783968A NO152651C NO 152651 C NO152651 C NO 152651C NO 783968 A NO783968 A NO 783968A NO 783968 A NO783968 A NO 783968A NO 152651 C NO152651 C NO 152651C
Authority
NO
Norway
Prior art keywords
cyanidan
preparation
therapeutically effective
substituted derivatives
analogy procedure
Prior art date
Application number
NO783968A
Other languages
English (en)
Other versions
NO783968L (no
NO152651B (no
Inventor
Alban Albert
Pierre Courbat
Andre Weith
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of NO783968L publication Critical patent/NO783968L/no
Publication of NO152651B publication Critical patent/NO152651B/no
Publication of NO152651C publication Critical patent/NO152651C/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
    • B32B37/28—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding involving assembly of non-flat intermediate products which are flattened at a later step, e.g. tubes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO783968A 1977-11-25 1978-11-24 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol NO152651C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1447977 1977-11-25
CH293778 1978-03-17

Publications (3)

Publication Number Publication Date
NO783968L NO783968L (no) 1979-05-28
NO152651B NO152651B (no) 1985-07-22
NO152651C true NO152651C (no) 1985-10-30

Family

ID=25691766

Family Applications (2)

Application Number Title Priority Date Filing Date
NO783968A NO152651C (no) 1977-11-25 1978-11-24 Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol
NO830800A NO830800L (no) 1977-11-25 1983-03-08 Fremgangsmaate for fremstilling av o-substituerte derivater av (+)-cyanidan-3-ol

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO830800A NO830800L (no) 1977-11-25 1983-03-08 Fremgangsmaate for fremstilling av o-substituerte derivater av (+)-cyanidan-3-ol

Country Status (21)

Country Link
US (2) US4255336A (no)
EP (2) EP0039844A3 (no)
JP (1) JPS5481274A (no)
AT (1) AT364835B (no)
AU (1) AU526985B2 (no)
CA (1) CA1171423A (no)
CS (1) CS228112B2 (no)
DD (2) DD148055A5 (no)
DE (1) DE2862384D1 (no)
DK (1) DK525778A (no)
ES (2) ES475338A1 (no)
FI (1) FI783593A (no)
HK (1) HK15287A (no)
IE (1) IE48250B1 (no)
IL (1) IL56030A (no)
MY (1) MY8700725A (no)
NO (2) NO152651C (no)
NZ (1) NZ189011A (no)
PL (1) PL120640B1 (no)
SG (1) SG82886G (no)
YU (1) YU41030B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285964A (en) * 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
EP0037800B1 (de) * 1980-04-03 1987-08-12 Zyma SA Verwendung von O-substituierten Derivaten von (+)-Cyanidanol-3 als Verbindungen mit immunomodulatorischen Eigenschaften
GB2122608B (en) * 1982-06-01 1985-10-02 Zyma Sa (+)-cyanidan-3-ol derivatives
GB2122987B (en) * 1982-06-01 1985-09-25 Zyma Sa (+)-cyanidan-3-ol derivatives and pharmaceutical preparations thereof
DE3715779A1 (de) * 1987-05-12 1988-11-24 Kali Chemie Pharma Gmbh Flavon-3-carbonsaeure-verbindungen sowie verfahren, zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP3165279B2 (ja) * 1993-03-29 2001-05-14 三井農林株式会社 ３−アシル化カテキンを含有する油溶性抗酸化剤
FR2706478B1 (fr) * 1993-06-14 1995-09-08 Ovi Sa Compositions de dérivés phénoliques, leur préparation et leurs applications comme anti-oxydants.
FR2728563B1 (fr) * 1994-12-21 1997-07-18 Ovi Sa Esters de composes polyhydroxyles aromatiques, leur preparation et leurs applications
US6207842B1 (en) * 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
DE69834582T2 (de) * 1998-06-18 2006-11-16 Consiglio Nazionale Delle Ricerche Biokatalytisches verfahren für die herstellung von 3-o-acyl-flavonoiden
US6156912A (en) * 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
US6476241B1 (en) 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
US7067679B2 (en) * 2002-10-02 2006-06-27 Mars, Inc. Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest
US7122573B2 (en) * 2002-12-06 2006-10-17 Sri International Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
KR20060082790A (ko) * 2003-06-20 2006-07-19 코그니스 프랑스 에스.에이.에스. ω-치환된 Ｃ６－Ｃ２２ 지방산을 갖는 플라보노이드의에스테르
TW200505468A (en) * 2003-08-11 2005-02-16 Suntory Ltd Agent for improving hepato-bililary dysfunction
AU2003267173B2 (en) * 2003-09-12 2009-09-10 Mitsui Norin Co., Ltd Antimicrobial compositions and methods of use
JP2007531734A (ja) * 2004-04-02 2007-11-08 インダストリアル・リサーチ・リミテッド パッションフルーツの抽出物及びその使用
ES2379079T3 (es) * 2004-09-14 2012-04-20 Ajinomoto Omnichem S.A. Polifenoles fosforilados como agentes de color estable
JP5064223B2 (ja) * 2004-09-22 2012-10-31 インドスペック ケミカル コーポレイション レゾルシノール−ケトン反応生成物由来のリン酸エステル難燃剤
JPWO2006080328A1 (ja) * 2005-01-26 2008-06-19 サントリー株式会社 カテキン類のエステル化物、その製造方法、および該エステル化物を含む飲食品あるいは化粧品
US20070004796A1 (en) * 2005-06-29 2007-01-04 Romanczyk Leo Jr Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallates
CN106565658A (zh) * 2016-10-21 2017-04-19 浙江大学 3‑硫酸基儿茶素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861992A (en) * 1955-08-29 1958-11-25 Rech S Et Tech Appliquees Derivatives of quercetin and to prodesses for their preparation
US3314975A (en) * 1963-01-25 1967-04-18 Jurd Leonard Flavylium compounds and methods of using them
FR7760M (no) * 1968-11-22 1970-03-16
US3661890A (en) * 1970-03-10 1972-05-09 Us Agriculture Preparation of quercetin derivatives
CH514574A (fr) * 1970-03-13 1971-10-31 Zyma Sa Procédé de fabrication de sels des acides épicatéchine sulfoniques-2
FR2128207B1 (no) * 1971-03-11 1974-08-02 Zyma Sa
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
DE2740346A1 (de) * 1976-09-08 1978-03-09 Inverni Della Beffa Spa Arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
YU41030B (en) 1986-10-31
PL211196A1 (pl) 1979-11-19
ES480605A1 (es) 1980-04-01
NO830800L (no) 1979-05-28
CA1171423A (en) 1984-07-24
DD141833A5 (de) 1980-05-21
CS228112B2 (en) 1984-05-14
AU526985B2 (en) 1983-02-10
EP0039844A3 (de) 1981-11-25
FI783593A (fi) 1979-05-26
AU4187778A (en) 1979-05-31
US4255336A (en) 1981-03-10
NZ189011A (en) 1981-01-23
YU275378A (en) 1982-10-31
SG82886G (en) 1987-07-03
IL56030A (en) 1985-08-30
JPS5481274A (en) 1979-06-28
PL120640B1 (en) 1982-03-31
ATA835678A (de) 1981-04-15
AT364835B (de) 1981-11-25
EP0003274A1 (de) 1979-08-08
EP0003274B1 (de) 1984-02-29
EP0039844A2 (de) 1981-11-18
DK525778A (da) 1979-05-26
DD148055A5 (de) 1981-05-06
MY8700725A (en) 1987-12-31
IE48250B1 (en) 1984-11-14
IL56030A0 (en) 1979-01-31
ES475338A1 (es) 1980-03-01
US4617296A (en) 1986-10-14
HK15287A (en) 1987-02-27
DE2862384D1 (en) 1984-04-05
NO783968L (no) 1979-05-28
NO152651B (no) 1985-07-22
IE782326L (en) 1979-05-25

Similar Documents

Publication Publication Date Title
NO152651C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 0-substituerte derivater av (+)-cyanidan-3-ol
SE431088B (sv) Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat
SE7811689L (sv) Forfarande for framstellning av maytansinoider
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO147562C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater
NO151201C (no) Fremgangsmaate for fremstilling av terapeutisk virksomme antigenderivater
NO773682L (no) Fremgangsmaate ved fremstilling av furocumariner
SE7802602L (sv) Forfarande for framstellning av alkoxisilanklusterforeningar
NO781168L (no) Fremgangsmaate ved fremstilling av diasepinderivater
SE7800963L (sv) Forfarande for framstellning av berarbundna acylaser
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
NO153260C (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme 9-hydroksyetoksyguaninderivater
SE434266B (sv) Forfarande for framstellning av prostacyklinderivat
SE7802530L (sv) Forfarande for framstellning av cefalosporinforeningar
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE7707114L (sv) Forfarande for framstellning av fast-tillstand-anordningar
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
NO771576L (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril
SE7805324L (sv) Forfarande for framstellning av 3-bromftalid
FI783743A (fi) Foerfarande foer framstaellning av 3-di-n-propyl-acetoxi-benzodiazepin-2-oner